Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
11,35 USD | +3,09 % | +1,25 % | -7,35 % |
Resumen de negocios
Número de empleados: 118
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ed Feener
FOU | Founder | 64 | 26/03/04 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01/08/16 |
Paul Audhya
CTO | Chief Tech/Sci/R&D Officer | 51 | 03/05/21 |
Ryan Baker
IRC | Investor Relations Contact | - | 01/05/23 |
Nicole Sweeny
PRN | Corporate Officer/Principal | 49 | 25/07/23 |
Christopher Yea
PRN | Corporate Officer/Principal | 61 | 01/11/16 |
Mike Smith
PRN | Corporate Officer/Principal | - | 01/02/16 |
Rachel Morten
LAW | General Counsel | - | 01/01/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Brian Pereira
CHM | Chairman | 65 | 01/02/19 |
Ben Palleiko
CEO | Chief Executive Officer | 58 | 01/08/16 |
Albert Cha
BRD | Director/Board Member | 51 | 01/01/16 |
Edward Unkart
BRD | Director/Board Member | 74 | 01/12/14 |
Nancy Stuart
BRD | Director/Board Member | 65 | 18/03/21 |
Patrick Treanor
BRD | Director/Board Member | - | 26/05/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 42 188 296 | 41 706 792 ( 98,86 %) | 0 | 98,86 % |
Información de la empresa
KalVista Pharmaceuticals, Inc.
55 Cambridge Parkway Suite 901 East
02142, Cambridge
+857 999 0075
http://www.kalvista.comRevisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-7,35 % | 479 M | |
-4,24 % | 86,85 mil M | |
+2,76 % | 40,16 mil M | |
-16,98 % | 31,28 mil M | |
+57,86 % | 25,27 mil M | |
-16,24 % | 15,33 mil M | |
-9,12 % | 11,96 mil M | |
-42,56 % | 11,61 mil M | |
-17,10 % | 11,69 mil M | |
+6,89 % | 8831,13 M |
- Bolsa de valores
- Acciones
- Acción KALV
- Empresa KalVista Pharmaceuticals, Inc.